Results 261 to 270 of about 33,444 (310)
Some of the next articles are maybe not open access.
Suicidality in Borderline Personality Disorder
Crisis, 1998Recent research on the relationship between borderline personality disorder (BPD) and suicidal behavior is reviewed. Risk factors for attempted and completed suicide as well as the effect of the comorbidity of BPD with other Axis I and II disorders are considered. Explanations for suicidality in BPD are discussed.
Carole Kjellander +2 more
openaire +3 more sources
Attachment and Borderline Personality Disorder
Psychiatric Clinics of North America, 2018Borderline personality disorder is associated with predominant insecure and unresolved attachment representations, linked history of trauma, impaired cognitive functioning and oxytocin levels, and higher limbic activations. Two randomized clinical trials on transference-focused psychotherapy assessed change of attachment representation and reflective ...
Diana Diamond, Anna Buchheim
openaire +2 more sources
Borderline personality: Traits and disorder.
Journal of Abnormal Psychology, 2000Although the 5-factor model (FFM) has been advocated as an alternative to representing the construct of borderline personality, some argue that this diagnosis carries essential information that is not well captured by the FFM. The present study examined antecedent, concurrent, and predictive markers of construct validity in a sample of 362 patients ...
Leslie C. Morey, Mary C. Zanarini
openaire +2 more sources
Disinhibition and borderline personality disorder
Development and Psychopathology, 2005We review different conceptions of inhibitory control that may be relevant to the regulatory problems featured in borderline personality disorder (BPD). These conceptions have often been framed with regard to personality traits of inhibitory control, but can also be related to cognitive measures of response suppression as well as affect regulation ...
Joel T. Nigg +3 more
openaire +3 more sources
Borderline Personality Disorder and Migraine
Headache: The Journal of Head and Face Pain, 2007Background.—Borderline personality disorder (BPD) may be disproportionately common in the migraine patient population, but specific migraine features in the BPD subgroup remain incompletely characterized.Purpose.—To define more clearly the clinical characteristics of migraine patients with BPD, to evaluate their clinical response to aggressive headache
Naomi S. Walters +5 more
openaire +3 more sources
Borderline Personality Disorder and Suicidality
American Journal of Psychiatry, 2006A 35-year-old woman, an academic professional, sought outpatient treatment for chronic dysphoria, a pattern of turbulent and unsuccessful interpersonal relationships, and a state of barely concealed rage that she attributed to the shortcomings and failures of others.
openaire +4 more sources
Borderline personality disorder and clozapine
Irish Journal of Psychological Medicine, 2007AbstractClozapine is an atypical anti-psychotic medication that has proved useful in the management of both psychotic and mood disorders and that has been shown to decrease aggression and the risk of suicide, which suggests that clozapine may be useful in the management of severe borderline personality disorder.
Emer Rutledge +2 more
openaire +3 more sources
Borderline Personality Disorder: An Overview
Social Work in Mental Health, 2008Our knowledge about borderline personality disorder (BPD) has taken some unexpected turns: BPD is less stable, it is more genetic, and it is more treatable than we would ever have imagined even 15 ...
openaire +2 more sources
Oxytocin and Borderline Personality Disorder
2017Borderline personality disorder (BPD) is a prevalent and severe mental disorder with affect dysregulation, impulsivity, and interpersonal dysfunction as its core features. Up to now, six studies have been performed to investigate the role of oxytocin in the pathogenesis of BPD.
Katja Bertsch, Sabine C. Herpertz
openaire +3 more sources
PSYCHOPHARMACOLOGY OF BORDERLINE PERSONALITY DISORDER
Psychiatric Clinics of North America, 2000Pharmacotherapy for patients with borderline personality disorder is directed against the psychobiology of cognitive-perceptual, affective, and impulsive-behavioral symptoms. A symptom-specific method using current empiric evidence for drug efficacy in each symptom domain is proposed.
openaire +3 more sources